The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Congestive Heart Failure (CHF) Treatment Devices Market Research Report 2025
Synopsis
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
The global Congestive Heart Failure (CHF) Treatment Devices market was valued at US$ 4984.2 million in 2023 and is anticipated to reach US$ 6369.4 million by 2030, witnessing a CAGR of 3.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Congestive Heart Failure (CHF) Treatment Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Congestive Heart Failure (CHF) Treatment Devices.
Report Scope
The Congestive Heart Failure (CHF) Treatment Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Congestive Heart Failure (CHF) Treatment Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Congestive Heart Failure (CHF) Treatment Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abiomed
Berlin Heart GmbH
Biotronik SE & Co. KG
Boston Scientific Corporation
HeartWare International
Jarvik Heart
LivaNova PLC
Medtronic
ReliantHeart
Abbott
Segment by Type
Cardiac Resynchronization Therapy (CRT)
Implantable Cardioverter Defibrillators (ICDs)
Segment by Application
Left Ventricular Assist Device (LVAD)
Right Ventricular Assist Device (RVAD)
Biventricular Assist Device (BIVAD)
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Congestive Heart Failure (CHF) Treatment Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Congestive Heart Failure (CHF) Treatment Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Congestive heart failure (CHF) is a physiological condition that has an adverse impact on the pumping efficiency of the cardiac muscles. It characterizes the accumulation of fluid around the heart leading to inefficient pumping. The onset of CHF is marked by the failure of the ventricles to pump sufficient volume of blood to the body organs. This eventually leads to deposition of fluid in the lungs, abdomen, liver, and lower body. CHF is treated by a number of devices that maintain heart rhythm, such as pacemakers, cardiac resynchronization therapy (CRT), implantable cardioverter defibrillators (ICDs), and ventricular assist devices (VADs).
The global Congestive Heart Failure (CHF) Treatment Devices market was valued at US$ 4984.2 million in 2023 and is anticipated to reach US$ 6369.4 million by 2030, witnessing a CAGR of 3.1% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Congestive Heart Failure (CHF) Treatment Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Congestive Heart Failure (CHF) Treatment Devices.
Report Scope
The Congestive Heart Failure (CHF) Treatment Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Congestive Heart Failure (CHF) Treatment Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Congestive Heart Failure (CHF) Treatment Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abiomed
Berlin Heart GmbH
Biotronik SE & Co. KG
Boston Scientific Corporation
HeartWare International
Jarvik Heart
LivaNova PLC
Medtronic
ReliantHeart
Abbott
Segment by Type
Cardiac Resynchronization Therapy (CRT)
Implantable Cardioverter Defibrillators (ICDs)
Segment by Application
Left Ventricular Assist Device (LVAD)
Right Ventricular Assist Device (RVAD)
Biventricular Assist Device (BIVAD)
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Congestive Heart Failure (CHF) Treatment Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Congestive Heart Failure (CHF) Treatment Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Congestive Heart Failure (CHF) Treatment Devices Market Overview
1.1 Product Overview and Scope of Congestive Heart Failure (CHF) Treatment Devices
1.2 Congestive Heart Failure (CHF) Treatment Devices Segment by Type
1.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Value Comparison by Type (2024-2030)
1.2.2 Cardiac Resynchronization Therapy (CRT)
1.2.3 Implantable Cardioverter Defibrillators (ICDs)
1.3 Congestive Heart Failure (CHF) Treatment Devices Segment by Application
1.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Value by Application: (2024-2030)
1.3.2 Left Ventricular Assist Device (LVAD)
1.3.3 Right Ventricular Assist Device (RVAD)
1.3.4 Biventricular Assist Device (BIVAD)
1.4 Global Congestive Heart Failure (CHF) Treatment Devices Market Size Estimates and Forecasts
1.4.1 Global Congestive Heart Failure (CHF) Treatment Devices Revenue 2019-2030
1.4.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales 2019-2030
1.4.3 Global Congestive Heart Failure (CHF) Treatment Devices Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Congestive Heart Failure (CHF) Treatment Devices Market Competition by Manufacturers
2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Manufacturers (2019-2024)
2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Congestive Heart Failure (CHF) Treatment Devices Average Price by Manufacturers (2019-2024)
2.4 Global Congestive Heart Failure (CHF) Treatment Devices Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Congestive Heart Failure (CHF) Treatment Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Congestive Heart Failure (CHF) Treatment Devices, Product Type & Application
2.7 Congestive Heart Failure (CHF) Treatment Devices Market Competitive Situation and Trends
2.7.1 Congestive Heart Failure (CHF) Treatment Devices Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Congestive Heart Failure (CHF) Treatment Devices Players Market Share by Revenue
2.7.3 Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Congestive Heart Failure (CHF) Treatment Devices Retrospective Market Scenario by Region
3.1 Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Congestive Heart Failure (CHF) Treatment Devices Global Congestive Heart Failure (CHF) Treatment Devices Sales by Region: 2019-2030
3.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Region: 2019-2024
3.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Region: 2025-2030
3.3 Global Congestive Heart Failure (CHF) Treatment Devices Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Region: 2019-2030
3.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Region: 2019-2024
3.3.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Region: 2025-2030
3.4 North America Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country
3.4.1 North America Congestive Heart Failure (CHF) Treatment Devices Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2019-2030)
3.4.3 North America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country
3.5.1 Europe Congestive Heart Failure (CHF) Treatment Devices Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2019-2030)
3.5.3 Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country
3.6.1 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2019-2030)
3.6.3 Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country
3.7.1 Latin America Congestive Heart Failure (CHF) Treatment Devices Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2019-2030)
3.7.3 Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2019-2030)
3.8.3 Middle East and Africa Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2019-2030)
4.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2019-2024)
4.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Type (2025-2030)
4.1.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2019-2030)
4.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2019-2030)
4.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2019-2024)
4.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2025-2030)
4.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2019-2030)
4.3 Global Congestive Heart Failure (CHF) Treatment Devices Price by Type (2019-2030)
5 Segment by Application
5.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2019-2030)
5.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2019-2024)
5.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Application (2025-2030)
5.1.3 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2019-2030)
5.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2019-2030)
5.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2019-2024)
5.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Application (2025-2030)
5.2.3 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2019-2030)
5.3 Global Congestive Heart Failure (CHF) Treatment Devices Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Abiomed
6.1.1 Abiomed Corporation Information
6.1.2 Abiomed Description and Business Overview
6.1.3 Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Abiomed Congestive Heart Failure (CHF) Treatment Devices Product Portfolio
6.1.5 Abiomed Recent Developments/Updates
6.2 Berlin Heart GmbH
6.2.1 Berlin Heart GmbH Corporation Information
6.2.2 Berlin Heart GmbH Description and Business Overview
6.2.3 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Product Portfolio
6.2.5 Berlin Heart GmbH Recent Developments/Updates
6.3 Biotronik SE & Co. KG
6.3.1 Biotronik SE & Co. KG Corporation Information
6.3.2 Biotronik SE & Co. KG Description and Business Overview
6.3.3 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Product Portfolio
6.3.5 Biotronik SE & Co. KG Recent Developments/Updates
6.4 Boston Scientific Corporation
6.4.1 Boston Scientific Corporation Corporation Information
6.4.2 Boston Scientific Corporation Description and Business Overview
6.4.3 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Product Portfolio
6.4.5 Boston Scientific Corporation Recent Developments/Updates
6.5 HeartWare International
6.5.1 HeartWare International Corporation Information
6.5.2 HeartWare International Description and Business Overview
6.5.3 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2019-2024)
6.5.4 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Product Portfolio
6.5.5 HeartWare International Recent Developments/Updates
6.6 Jarvik Heart
6.6.1 Jarvik Heart Corporation Information
6.6.2 Jarvik Heart Description and Business Overview
6.6.3 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Product Portfolio
6.6.5 Jarvik Heart Recent Developments/Updates
6.7 LivaNova PLC
6.6.1 LivaNova PLC Corporation Information
6.6.2 LivaNova PLC Description and Business Overview
6.6.3 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2019-2024)
6.4.4 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Product Portfolio
6.7.5 LivaNova PLC Recent Developments/Updates
6.8 Medtronic
6.8.1 Medtronic Corporation Information
6.8.2 Medtronic Description and Business Overview
6.8.3 Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Medtronic Congestive Heart Failure (CHF) Treatment Devices Product Portfolio
6.8.5 Medtronic Recent Developments/Updates
6.9 ReliantHeart
6.9.1 ReliantHeart Corporation Information
6.9.2 ReliantHeart Description and Business Overview
6.9.3 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2019-2024)
6.9.4 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Product Portfolio
6.9.5 ReliantHeart Recent Developments/Updates
6.10 Abbott
6.10.1 Abbott Corporation Information
6.10.2 Abbott Description and Business Overview
6.10.3 Abbott Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Abbott Congestive Heart Failure (CHF) Treatment Devices Product Portfolio
6.10.5 Abbott Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Congestive Heart Failure (CHF) Treatment Devices Industry Chain Analysis
7.2 Congestive Heart Failure (CHF) Treatment Devices Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Congestive Heart Failure (CHF) Treatment Devices Production Mode & Process
7.4 Congestive Heart Failure (CHF) Treatment Devices Sales and Marketing
7.4.1 Congestive Heart Failure (CHF) Treatment Devices Sales Channels
7.4.2 Congestive Heart Failure (CHF) Treatment Devices Distributors
7.5 Congestive Heart Failure (CHF) Treatment Devices Customers
8 Congestive Heart Failure (CHF) Treatment Devices Market Dynamics
8.1 Congestive Heart Failure (CHF) Treatment Devices Industry Trends
8.2 Congestive Heart Failure (CHF) Treatment Devices Market Drivers
8.3 Congestive Heart Failure (CHF) Treatment Devices Market Challenges
8.4 Congestive Heart Failure (CHF) Treatment Devices Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Congestive Heart Failure (CHF) Treatment Devices Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Congestive Heart Failure (CHF) Treatment Devices Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Congestive Heart Failure (CHF) Treatment Devices Market Competitive Situation by Manufacturers in 2023
Table 4. Global Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Congestive Heart Failure (CHF) Treatment Devices Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Congestive Heart Failure (CHF) Treatment Devices, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Congestive Heart Failure (CHF) Treatment Devices, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Congestive Heart Failure (CHF) Treatment Devices, Product Type & Application
Table 12. Global Key Manufacturers of Congestive Heart Failure (CHF) Treatment Devices, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Congestive Heart Failure (CHF) Treatment Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Congestive Heart Failure (CHF) Treatment Devices as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2019-2024) & (K Units)
Table 18. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2019-2024)
Table 19. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2025-2030) & (K Units)
Table 20. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2025-2030)
Table 21. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region (2019-2024)
Table 23. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region (2025-2030)
Table 25. North America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2019-2024) & (K Units)
Table 27. North America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2025-2030) & (K Units)
Table 28. North America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2019-2024) & (K Units)
Table 32. Europe Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2025-2030) & (K Units)
Table 33. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) by Type (2019-2024)
Table 51. Global Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) by Type (2025-2030)
Table 52. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2019-2024)
Table 53. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Type (2025-2030)
Table 54. Global Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2019-2024)
Table 57. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Type (2025-2030)
Table 58. Global Congestive Heart Failure (CHF) Treatment Devices Price (USD/Unit) by Type (2019-2024)
Table 59. Global Congestive Heart Failure (CHF) Treatment Devices Price (USD/Unit) by Type (2025-2030)
Table 60. Global Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) by Application (2019-2024)
Table 61. Global Congestive Heart Failure (CHF) Treatment Devices Sales (K Units) by Application (2025-2030)
Table 62. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2019-2024)
Table 63. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Application (2025-2030)
Table 64. Global Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Congestive Heart Failure (CHF) Treatment Devices Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2019-2024)
Table 67. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Application (2025-2030)
Table 68. Global Congestive Heart Failure (CHF) Treatment Devices Price (USD/Unit) by Application (2019-2024)
Table 69. Global Congestive Heart Failure (CHF) Treatment Devices Price (USD/Unit) by Application (2025-2030)
Table 70. Abiomed Corporation Information
Table 71. Abiomed Description and Business Overview
Table 72. Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Abiomed Congestive Heart Failure (CHF) Treatment Devices Product
Table 74. Abiomed Recent Developments/Updates
Table 75. Berlin Heart GmbH Corporation Information
Table 76. Berlin Heart GmbH Description and Business Overview
Table 77. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Product
Table 79. Berlin Heart GmbH Recent Developments/Updates
Table 80. Biotronik SE & Co. KG Corporation Information
Table 81. Biotronik SE & Co. KG Description and Business Overview
Table 82. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Product
Table 84. Biotronik SE & Co. KG Recent Developments/Updates
Table 85. Boston Scientific Corporation Corporation Information
Table 86. Boston Scientific Corporation Description and Business Overview
Table 87. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Product
Table 89. Boston Scientific Corporation Recent Developments/Updates
Table 90. HeartWare International Corporation Information
Table 91. HeartWare International Description and Business Overview
Table 92. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Product
Table 94. HeartWare International Recent Developments/Updates
Table 95. Jarvik Heart Corporation Information
Table 96. Jarvik Heart Description and Business Overview
Table 97. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Product
Table 99. Jarvik Heart Recent Developments/Updates
Table 100. LivaNova PLC Corporation Information
Table 101. LivaNova PLC Description and Business Overview
Table 102. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Product
Table 104. LivaNova PLC Recent Developments/Updates
Table 105. Medtronic Corporation Information
Table 106. Medtronic Description and Business Overview
Table 107. Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Medtronic Congestive Heart Failure (CHF) Treatment Devices Product
Table 109. Medtronic Recent Developments/Updates
Table 110. ReliantHeart Corporation Information
Table 111. ReliantHeart Description and Business Overview
Table 112. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Product
Table 114. ReliantHeart Recent Developments/Updates
Table 115. Abbott Corporation Information
Table 116. Abbott Description and Business Overview
Table 117. Abbott Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Abbott Congestive Heart Failure (CHF) Treatment Devices Product
Table 119. Abbott Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Congestive Heart Failure (CHF) Treatment Devices Distributors List
Table 123. Congestive Heart Failure (CHF) Treatment Devices Customers List
Table 124. Congestive Heart Failure (CHF) Treatment Devices Market Trends
Table 125. Congestive Heart Failure (CHF) Treatment Devices Market Drivers
Table 126. Congestive Heart Failure (CHF) Treatment Devices Market Challenges
Table 127. Congestive Heart Failure (CHF) Treatment Devices Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Congestive Heart Failure (CHF) Treatment Devices
Figure 2. Global Congestive Heart Failure (CHF) Treatment Devices Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Type in 2023 & 2030
Figure 4. Cardiac Resynchronization Therapy (CRT) Product Picture
Figure 5. Implantable Cardioverter Defibrillators (ICDs) Product Picture
Figure 6. Global Congestive Heart Failure (CHF) Treatment Devices Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Congestive Heart Failure (CHF) Treatment Devices Market Share by Application in 2023 & 2030
Figure 8. Left Ventricular Assist Device (LVAD)
Figure 9. Right Ventricular Assist Device (RVAD)
Figure 10. Biventricular Assist Device (BIVAD)
Figure 11. Global Congestive Heart Failure (CHF) Treatment Devices Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Congestive Heart Failure (CHF) Treatment Devices Market Size (2019-2030) & (US$ Million)
Figure 13. Global Congestive Heart Failure (CHF) Treatment Devices Sales (2019-2030) & (K Units)
Figure 14. Global Congestive Heart Failure (CHF) Treatment Devices Average Price (USD/Unit) & (2019-2030)
Figure 15. Congestive Heart Failure (CHF) Treatment Devices Report Years Considered
Figure 16. Congestive Heart Failure (CHF) Treatment Devices Sales Share by Manufacturers in 2023
Figure 17. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Congestive Heart Failure (CHF) Treatment Devices Players: Market Share by Revenue in 2023
Figure 19. Congestive Heart Failure (CHF) Treatment Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Congestive Heart Failure (CHF) Treatment Devices Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2019-2030)
Figure 22. North America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2019-2030)
Figure 26. Europe Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2019-2030)
Figure 27. Germany Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Region (2019-2030)
Figure 34. China Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2019-2030)
Figure 45. Latin America Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Congestive Heart Failure (CHF) Treatment Devices Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Congestive Heart Failure (CHF) Treatment Devices by Type (2019-2030)
Figure 55. Global Revenue Market Share of Congestive Heart Failure (CHF) Treatment Devices by Type (2019-2030)
Figure 56. Global Congestive Heart Failure (CHF) Treatment Devices Price (USD/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Congestive Heart Failure (CHF) Treatment Devices by Application (2019-2030)
Figure 58. Global Revenue Market Share of Congestive Heart Failure (CHF) Treatment Devices by Application (2019-2030)
Figure 59. Global Congestive Heart Failure (CHF) Treatment Devices Price (USD/Unit) by Application (2019-2030)
Figure 60. Congestive Heart Failure (CHF) Treatment Devices Value Chain
Figure 61. Congestive Heart Failure (CHF) Treatment Devices Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
